SEC Form 4 research

Eloxx Pharmaceuticals, Inc. insider transactions

IssuerEloxx Pharmaceuticals, Inc.
TickersELOX, SVON, SNTI, SVOND, SNT
Reporting owners61
Officers and directors16
Last public filing2026-10-21

Recent insider disclosures

AvailableTrade dateReporting ownersCodeSharesPriceReported value
2026-10-212026-10-19Germano Geno JA13,587$0Not reported

Officers and directors in the directory

Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.

NexusTrade Loading NexusTrade… Taking too long? Reload this page